Attractively, novel anti-RA therapeutics had been developed currently such as antagonizing targets to histamine H4, histone deacetylase, LHRH (luteinizing hormone-releasing hormone), cadherin, MMP-9, CX3C ligand 1, and TLR4. The gene discussed is GNRH1; the disease is rheumatoid arthritis.